Mutational analysis of DMD gene reveals two novel small deletions in patients bearing no large deletions or duplications

Publish Year: 1393
نوع سند: مقاله کنفرانسی
زبان: English
View: 1,072

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CIGS13_0712

تاریخ نمایه سازی: 7 بهمن 1393

Abstract:

Dystrinopathies are inherited muscular dystrophies with mutations in DMD gene which contains 79 exons and is the largest human gene. DMD encodes Dystrophin protein and is the only gene responsible for the spectrum of dystrinopathies. Genotype analysis has indicated that deletions of one or more exon account for ~65% of all cases, while 5-10% are in-frame or out-frame duplications and the remaining 30% of affected individuals may have point mutations, small deletions orinsertions within the gene. In the present study, two patients diagnosed with Duchenne muscular dystrophy (DMD) are investigated. Multiple ligationdependent probe amplification (MLPA) analysis which detects up to 98% of all deletions and duplications in DMD gene didnot reveal any large rearrangement in these patients. Further investigation with application of two different techniques led toidentification of two novel small deletions in DMD gene. In the first patient, all coding as well as flanking intronic regions of the dystrophin gene were PCR-amplified followed by sequencing and a hemizygous novel deletion; c.650-16_653del20 (p.D217V fs11X) was detected. Next, whole exomesequencing was applied to investigate the causative variant in the second patient that revealed another novel hemizygousdeletion defined as c.8297delT (p.Leu2766Arg fsX17). The identified variant was confirmed by Sanger sequencing in the proband as well as other family members. This result extends the mutational spectrum of the disease by introducing two novel mutations in DMD gene and is another indication that the advent of recent technologies such as whole exome sequencing has made the diagnostic approaches much easier

Authors

Zohreh Fattahi

Genetics Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.

Gholamerza Zamani

Department of Pediatric Neurology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Mahsa Fadaee

Genetics Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.

Mohammad Reza Akbari

Women’s College Research Institute, University of Toronto, Toronto, ON, Canada.